Search This Blog

Sunday, May 30, 2021

Shape Therapeutics to Present Discovery of Muscle-Specific AAVs at Jefferies Virtual Healthcare Confab

 Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced that Francois Vigneault, PhD, President and Chief Executive Officer, is scheduled to present virtually at the Jefferies 2021 Virtual Healthcare Conference on Thursday, June 3, 2021 at 4:00 p.m. Eastern Time. The presentation will highlight the discovery of muscle-specific AAVs in non-human primates (NHP) that are detuned for the liver using the ShapeTX AAVidTM platform. The AAVidTM capsid discovery platform screens billions of engineered AAV variants directly in NHP and applies AI-powered bioinformatics to identify proprietary predictive features driving tissue tropism and accelerate the development of superior gene therapies.

https://www.streetinsider.com/Globe+Newswire/UPDATE+%E2%80%93+Shape+Therapeutics+to+Present+the+Discovery+of+Muscle-Specific+AAVs+at+the+Jefferies+2021+Virtual+Healthcare+Conference/18497386.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.